Our latest release adds an integrated suite of molecular biology tools, a chemical registry, and support for antibody-drug conjugates
StackWave Affinity v16 Announcement - Next Generation Sequencing
The sunk cost fallacy can affect our decision making around LIMS, other software, and antibody discovery technology purchases.
StackWave Affinity™ takes a fundamentally different approach than other software solutions to the unique challenges of Antibody Discovery teams.
Every year, StackWave delivers a steady stream of improvements to our Affinity antibody discovery solution, and 2022 was no exception.
Rapid Feedback in antibody drug discovery can quickly identify issues in format, development, manufacturing, and discovery approaches and processes
Antibody sequence analysis and lead identification automation through software scripts as a means of Workflow Automation.